Merck & Company Inc (MRK)vsSo-Young International Inc (SY)
MRK
Merck & Company Inc
$148.81
+0.54%
HEALTHCARE · Cap: $365.34B
SY
So-Young International Inc
$2.70
0.00%
HEALTHCARE · Cap: $276.69M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 3913% more annual revenue ($66.57B vs $1.66B). MRK leads profitability with a 4.8% profit margin vs -15.6%. SY earns a higher WallStSmart Score of 42/100 (D).
MRK
Hold36
out of 100
Grade: F
SY
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-78.2%
Fair Value
$83.04
Current Price
$148.81
$65.77 premium
Intrinsic value data unavailable for SY.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Reasonable price relative to book value
Revenue surging 45.6% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Trading at 8.8x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Distress zone — elevated risk
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : SY
The strongest argument for SY centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 45.6% demonstrates continued momentum.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 120.4x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : SY
The primary concerns for SY are Market Cap, Return on Equity, Altman Z-Score.
Key Dynamics to Monitor
MRK profiles as a value stock while SY is a hypergrowth play — different risk/reward profiles.
SY carries more volatility with a beta of 2.13 — expect wider price swings.
SY is growing revenue faster at 45.6% — sustainability is the question.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SY scores higher overall (42/100 vs 36/100) and 45.6% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →So-Young International Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · China
So-Young International Inc. operates an online platform for consumer health and medical aesthetic services that focuses on discretionary medical treatments.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?